These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13648321)

  • 1. [Effect of injectable Crataegus extracts on hyperpyruvemias of cardiac genesis].
    PIATY R
    Wien Klin Wochenschr; 1959 Mar; 71(12):213-4. PubMed ID: 13648321
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and experimental studies of the effect of an injectable Crataegus extract].
    KOPPERMANN E
    Arztl Forsch; 1956 Dec; 10(12):I/585-92. PubMed ID: 13394436
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiences with an injectable Crataegus preparation].
    HABERECHT I
    Med Klin; 1957 Feb; 52(5):185-7. PubMed ID: 13418230
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic studies on the method of action of Crataegus extracts in cardiac insufficiency].
    WERNZE H
    Z Kreislaufforsch; 1958 Jun; 47(11-12):514-34. PubMed ID: 13570227
    [No Abstract]   [Full Text] [Related]  

  • 5. [Digitalis-lanata-Crataegus in therapy of heart diseases].
    LEUTIGER H
    Medizinische; 1957 Jun; (26):984-7. PubMed ID: 13451036
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiogenic hyperpyruvemia as a manifestation of myocardial metabolism disorder and its medical control].
    KANTHER R
    Munch Med Wochenschr; 1962 Jan; 104():40-5. PubMed ID: 14453659
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with an injectable preparation of Crataegus oxyacantha].
    ANDRE W
    Ther Ggw; 1957 May; 96(5):170-4. PubMed ID: 13442944
    [No Abstract]   [Full Text] [Related]  

  • 8. [Crataegus in treatment of heart diseases].
    WINDUS H
    Dtsch Med Wochenschr; 1955 Sep; 80(39):1429-31. PubMed ID: 13261727
    [No Abstract]   [Full Text] [Related]  

  • 9. [A CONTRIBUTION TO CRATAEGUS INDICATIONS].
    LEONHARD H
    Med Welt; 1963 Sep; 38():1943-5. PubMed ID: 14056584
    [No Abstract]   [Full Text] [Related]  

  • 10. [GLYCOSIDE THERAPY WITH OR WITHOUT CRATAEGUS?].
    MUCK R
    Hippokrates; 1963 Aug; 34():673-5. PubMed ID: 14047202
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with parenteral Crataegus therapy].
    SCHLOTE K
    Med Klin; 1957 Jan; 52(3):104-5. PubMed ID: 13407402
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indication & evaluation of treatment of heart disease with crataegutt].
    MENZEL M
    Ther Ggw; 1957 Jun; 96(6):211-3. PubMed ID: 13455621
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
    Degenring FH; Suter A; Weber M; Saller R
    Phytomedicine; 2003; 10(5):363-9. PubMed ID: 12833999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-experimental metabolic studies using a Crataegus extract].
    Hammerl H; Kränzl C; Pichler O; Studlar M
    Arztl Forsch; 1967 Jul; 21(7):261-4. PubMed ID: 5631903
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of heart diseases with Crataegus oxyacantha and Sarothamnus scoparius].
    ACKERMANN J
    Ther Ggw; 1957 Jan; (1):4-8. PubMed ID: 13422357
    [No Abstract]   [Full Text] [Related]  

  • 16. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
    Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK
    Arzneimittelforschung; 2001 Oct; 51(10):793-8. PubMed ID: 11715631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical treatment of arrhythmia with the injectable Crataegus extract esbericard].
    LAYER H
    Munch Med Wochenschr; 1957 Dec; 99(52):1980-2. PubMed ID: 13504081
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of serum pyruvic acid and alpha-ketoglutaric acid in congestive heart failure].
    GAVOSTO F; BUFFA F; CHIARLE S; SOLERIO F
    Minerva Med; 1958 Jan; 49(1-2):66-71. PubMed ID: 13516731
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of the blood pyruvic acid level in patients with congestive heart failure.
    KLEEBERG J; GITELSON S
    J Clin Pathol; 1954 May; 7(2):116-21. PubMed ID: 13163193
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of changes in blood lactic and pyruvic acid levels in cardiac decompensation].
    ANTALOCZY Z; BRETAN M; LOVEI E
    Magy Belorv Arch (1955); 1956 Aug; 9(4):130-5. PubMed ID: 13377781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.